y 27632 has been researched along with at13148 in 1 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (at13148) | Trials (at13148) | Recent Studies (post-2010) (at13148) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 12 | 2 | 12 |
| Protein | Taxonomy | y 27632 (IC50) | at13148 (IC50) |
|---|---|---|---|
| Rho-associated protein kinase 2 | Homo sapiens (human) | 0.01 | |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | 0.012 | |
| Ribosomal protein S6 kinase alpha-4 | Homo sapiens (human) | 0.012 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | 0.01 | |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | 0.012 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 0.3827 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.504 | |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | 0.012 | |
| Ribosomal protein S6 kinase alpha-2 | Homo sapiens (human) | 0.012 | |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | 0.012 | |
| Ribosomal protein S6 kinase beta-2 | Homo sapiens (human) | 0.012 | |
| Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | 0.012 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.3867 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cutiongco, MF; Gadegaard, N; Jagiełło, A; Kamphorst, JJ; Mackay, G; McGarry, L; Michalopoulou, E; Munro, J; Olson, MF; Pajic, M; Rath, N; Sumpton, D; Timpson, P; Unbekandt, M; Vennin, C | 1 |
1 other study(ies) available for y 27632 and at13148
| Article | Year |
|---|---|
Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 2-Hydroxyphenethylamine; Amides; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Female; HEK293 Cells; Humans; Male; Mice; Neoplasm Invasiveness; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyridines; rho-Associated Kinases; Signal Transduction | 2018 |